Peak6 »

Taysha Gene Therapies shares owned by Peak6

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Peak6 from 13F filings

Historical chart of Peak6 investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Peak6 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Peak6

Quarter filed Position value Share count Share price at filing
2025-12-31 $82k 15k 5.50

More positions owned by Peak6

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Meta Platforms Cl A Call Option (META)
Coreweave Com Cl A Call Option (CRWV)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Apple Call Option (AAPL)
Micron Technology Call Option (MU)
Broadcom Call Option (AVGO)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Ishares Silver Tr Ishares Call Option (SLV)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for Peak6

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies